期刊文献+

磷脂酶A2受体基因多态性与缺血性脑卒中关系的研究

A population-based study of phospholipase A2 recepter gene for ischemic stroke in a Chinese population
下载PDF
导出
摘要 目的探讨磷脂酶A2受体基因多态性与缺血性脑卒中的关系。方法以rs2203053和rs4665135位点为遗传标记,应用多聚酶链-限制性片段长度多态性(PCR-RFLP)技术检测643例缺血性脑卒中患者和404例健康对照人群的磷脂酶A2受体基因型。结果缺血性脑卒中组与对照组rs2203053和rs4665135位点的等位基因、基因型频率差异无显著性。结论磷脂酶A2受体基因与缺血性脑卒中的发病可能无关。 Objective To investigate the genetic association between the PLA2R gene and ischemic stroke. Methotis 643 patients with ischemic stroke were recruited into this study, and 404 healthy people were as controls. SNP rs2203053,a C to T base change located in intron 3,and rs4665135,a C to T base change located in intron 9 of the gene, were used as genetic markers. PCR-based restriction fragment length polymorphism analysis was applied to genotype rs2203053 and rs4665135 (Bstn I and Hae Ⅲ site). Results The frequency of allele C, and genotype CC, CT and T1p showed no association between cases and controls. Conclusion The present study suggests that the PLA2R gene is unlikely to contribute to the etiology of ischemic stroke in Chinese.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2008年第3期316-318,共3页 Journal of Apoplexy and Nervous Diseases
基金 吉林省科技厅资助项目(20060413-1)
关键词 缺血性脑卒中 磷脂酶A2受体 单核苷酸多态性(SNP) Stroke Phospholipase A2 Gene Single nucleotide polymorphism(SNP)
  • 相关文献

参考文献11

  • 1宰春和,饶明俐.关于脑卒中的遗传学研究[J].中风与神经疾病杂志,1993,10(3):184-186. 被引量:1
  • 2Six DA, Dennis EA. The expanding super-family of phospholipase A2 enzymes : classification and characterization [ J ]. Biochim Biophys Acta ,2000,1488(1-2) : 1-19.
  • 3Hanasaki K, Arita H. Phospholipase A2 receptor : a regulator of biological functions of secretory phospholipase A2[J]. Prostaglandins Other Lipid Mediat ,2002,68:71-82.
  • 4Adams HP,Bendixen BH,Kappelle LJ,et al. Classification of subtype of acute ischemic stroke,definition for use in a multicenter clinical trial[ J]. Stroke, 1993,24( 1 ) :35-41.
  • 5Ross R. Atherosclerosis-an inflammatory disease[ review] [ J]. N Engl J Med, 1999,340 : 115 - 126.
  • 6Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men[ J]. N Engl J Med,1997,336:973 979.
  • 7Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack:the Framingham study[ J]. Stroke,2001,32:2575 - 2579.
  • 8Park DW, Kim JR, Kim SY, et al. Akt as a mediator of secretory phospholipase A2 receptor-involved inducible nitric oxide synthase expression [ J ]. J Immunol,2003,170 (4) :2093-2099.
  • 9Dixon DA, Tolley ND, Bemis-Standoli K, et al. Expression of COX-2 in platelet-monocyle interactions occurs via combinatorial regulation involving adhesion and cytokine signaling [ J ]. J Clin Invest, 2006, 116(10) :2727-2738.
  • 10Ancian P, Lambeau G, Mattei MG, et al. The human 180-kDa receptor for secretory phospholipases A2 : molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization [ J]. J Biol Chem, 1995,270:8963-8970.

二级参考文献9

  • 1Six DA,Dennis EA. The expanding super-family of phospholipase A2 enzymes : classification and characterization [J]. Biochim Biophys Acta, 2000,1488(1-2): 1-19.
  • 2Akiba S, Sato T. Cellular function of calcium-independent phos pholipase A2[J]. Biol Pharm Bull, 2004,27 : 1174-1178.
  • 3Kovanen P,Pentikainen M. Secretory group II phospholipase A (2):a newly recognized acut-phase reactant with a role in atherogenesis[J]. Circ Res,2000,86(6) : 610-612.
  • 4Hurt-Camejo E,Camejo G, Peilot H, et al. Phospholipase A2 in Vascular Disease [J]. Circ Res, 2001,89 (4) : 298-304.
  • 5Aneian P. The human 180-kDa receptor for secretory phospholipases A2, Molecular cloning,identification of a secreted soluble form,expression,and chromosomal localization[J]. J Biol Chem, 1995,270(15):8963-8970.
  • 6Amandine Jaulmes, Brigitte Janvier, M arise Andreani, et al. Au tocrine and paracrine transcriptional regulation of type ⅡA secretory phospholipase A2 gene in vascular smooth muscle cells[J]. Arterioscler Thromb Vase Biol,2005,25(6) : 1161-1167.
  • 7Hernandez M, Fuentes L, Fernandez Aviles FH, et al. Secretory phospholipase A(2) elicits prolnflammatory changes and upregula tes the surface expression of fas ligand in monocytic cells : potential relevance for atherogenesis [J]. Circ Res, 2002,90 (1): 38-45.
  • 8Park DW,Kim JR,Kun SY,et al. Akt as a mediator of secretory phospholipase A2 receptor-involved inducible nitric oxide synthase expression[J]. J Immunol, 2003,170 (4) : 2093-2099.
  • 9Boilard E,Rouault M, Surrel F,et al. Secreted phospholipase a (2) inhibitnrs are also potent blockers of binding to the m-type receptor[J]. Biochemistry,2006,45(44) : 13203-18.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部